Does diabetes make cancer treatment harder? new study investigates
NCT ID NCT07466212
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study looks at how having type 2 diabetes impacts quality of life in cancer patients receiving immunotherapy. Researchers will compare changes in well-being over six months between patients with and without diabetes. About 920 adults with solid tumors will fill out quality-of-life surveys at the start, then at 3 and 6 months. The goal is to understand if diabetes adds extra challenges during cancer treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Afdeling for Kræftbehandling, Herlev Hospital
Herlev, 2730, Denmark
-
Kræftafdelingen, Aarhus Universitetshospital
Aarhus, 8000, Denmark
-
Onkologisk afdeling, Klinik Kirurgi og Kræftbehandling
Aalborg, 9000, Denmark
-
Sygehus Lillebælt, Onkologisk afdeling Vejle
Vejle, 7100, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare